NewsMedicinal CannabisOverseed Becomes First Company To Cultivate Medical Cannabis In...

Overseed Becomes First Company To Cultivate Medical Cannabis In France

-

As reported by NewsWeed

SIX months after obtaining ANSM (French Agency for the Safety of Health products) approval and raising €2.5 million, Overseed is launching a new research and development program in the cultivation of medical cannabis. 

In doing so it has become the first company to cultivate cannabis for medical purposes in France.

By the end of the year, the biotech firm aims to select five plants on which its first pharmaceutical trials will be initiated.

Research Runs

After receiving its authorisation to legally conduct research on cannabis for therapeutic purposes for the first time, Overseed began its first agronomic phase of phenotyping plants two months ago.

This process aims to select plants with precise agronomic criteria and phytochemical profiles, which will guarantee the stability of production and the reliability of cannabis varieties. 

In the second phase, the production of these varieties will be tested in a controlled climate to ensure the stability and homogeneity of the plants.

This research and development programme, the first of its kind in the country, is due to be completed some time in 2023, coinciding with the completion of an ANSM medical cannabis pilot project. 

Production Runs

By the end of 2022, the Overseed team plans to select five varieties of plants that meet the requirements to start the “pharmaceutical run” phase.

The process of extracting the active ingredients from the cannabis plant will then make it possible to develop new drugs that meet the specifications of the ANSM. 

Overseed will develop its extracts with Stanipharm CDMO, an expert in the production of active ingredients, in particular by supercritical CO2 extraction.

“We are very excited to begin this complex agronomic and scientific process that is critical to future drug development. In the coming months, our experts in genetics and cultivation techniques will be fully invested in bringing to medical research as well as to our partners, all the potential of this plant,”  said Hugues Péribère, founder and CEO of Overseed, in a press release. .

“It is also a further step for the French pharmaceutical industry, its sovereignty and its ability to respond to the many medical uses of cannabis. Through our project, we combine the best French expertise to create an innovative and efficient value chain in the territory. The next few months will be devoted to the search for operating laboratory partners and distributors”.

Latest news

British People Open To Using Medical Cannabis – Yet Majority Unaware They Can Access It On Prescription 

A NEW national survey of 4,000 people has highlighted the need to improve awareness of cannabis as a medicine.  Key...

As US Hemp Cultivation Levels Plummet The Established European Industry Continues To Flourish 

DESPITE a huge decline in US hemp industry’s footprint the European industry will continue to grow, say the continent’s...

Chrystal Capital Acts As Exclusive Advisor To Change Agronomy On £9.6m Fundraise

CHRYSTAL Capital Partners LLP, is an entrepreneurial corporate finance and investment house with an established global network of Single...

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of a lull with little movement for European cannabis stocks. Last week’s...

Business of Cannabis Conference Returns to New York City on November 3rd

In this second summit, the most influential business leaders, investors and politicians gather to discuss social equity, policy and...

Curaleaf Takes Majority Stake And Forms Strategic Partnership With Germany’s Four 20 Pharma In €20m Deal

CURALEAF Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading U.S. provider of consumer products in cannabis, announced that Curaleaf International...

Must read

As US Hemp Cultivation Levels Plummet The Established European Industry Continues To Flourish 

DESPITE a huge decline in US hemp industry’s footprint...

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of...

You might also likeRELATED
Recommended to you